Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.3.9SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
DV.7.1.4SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
XCLSWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
JE.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
JN.1.30SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
B.11SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
GJ.5SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
GJ.1.2.2SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
XBB.1.16.17SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
HK.23.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
JR.1.1.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
HK.8SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
XDESWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
KH.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
JN.1.55SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
GK.2SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
JY.1.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
XCQSWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
GS.3SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
CH.1.1.32SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
FL.20.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
GW.4SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
HY.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
GK.7SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
EG.2.5SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
XBB.1.5.11SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
FL.33SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
FL.39.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
FD.1.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
FT.3SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
JN.1.4.6SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1403.3Japan
XBB.1.11.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-1387.67South Korea
BA.5.1.22ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-1355.31France
BA.5.5ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-1355.31France
CH.1.1.28ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-1355.31France
CH.1.1.19ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-1355.31France
BM.4.1.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-1355.31France
BA.5.2.35ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-1355.31France
unclassifiableORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-1355.31France
BE.1.1.2ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-1355.31France
BF.7ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-1355.31France
BQ.1.1.8ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-1355.31France
BA.5.5.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-1355.31France
CH.1.1.6ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-1355.31France
CH.1.1.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-1355.31France
BQ.1.2ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-1355.31France
BQ.1.1.19ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-1355.31France
BA.4 (Omicron)ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-1355.31France
BA.1.1.15ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-1355.31France
DV.3ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-1341.81Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used